Carregant...

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates

PURPOSE: Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Causes Control
Autors principals: Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://ncbi.nlm.nih.gov/pubmed/26458884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-015-0678-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!